Karyopharm Therapeutics KPTI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.36 | 19.90 | -7.00 | -17,844 | -102 | |
| 2025Q3 | 6.54 | 68.92 | -3.82 | -15,220 | -33 | |
| 2025Q2 | 4.31 | 93.85 | -4.32 | -24,387 | -37 | |
| 2025Q1 | 3.74 | 267.50 | -2.77 | -33,256 | -23 | |
| 2024Q4 | 10.14 | 158.91 | -3.60 | -31,281 | -31 | |
| 2024Q3 | 12.45 | 127.22 | -3.15 | -26,283 | -32 | |
| 2024Q2 | 13.01 | -85.71 | -2.35 | -28,120 | 24 | |
| 2024Q1 | 22.65 | 107.49 | -4.85 | -33,759 | -37 | |
| 2023Q4 | 12.98 | 106.50 | -5.40 | -37,808 | -42 | |
| 2023Q3 | 20.10 | 109.99 | -4.50 | -31,260 | -35 | |
| 2023Q2 | 26.85 | 110.68 | -4.35 | -29,573 | -33 | |
| 2023Q1 | 58.35 | 109.13 | -4.50 | -30,899 | -34 | |
| 2022Q4 | 51.00 | 104.06 | -6.30 | -33,869 | -39 | |
| 2022Q3 | 81.90 | 102.23 | -6.75 | -30,839 | -36 | |
| 2022Q2 | 67.65 | 100.66 | -9.30 | -42,908 | -49 | |
| 2022Q1 | 110.55 | 100.00 | -7.95 | -34,586 | -41 | |
| 2021Q4 | 96.45 | 100.91 | 7.80 | 46,962 | 39 | |
| 2021Q3 | 87.30 | 100.27 | -10.35 | -43,812 | -52 | |
| 2021Q2 | 154.80 | 101.24 | -10.65 | -49,048 | -54 | |
| 2021Q1 | 157.80 | 100.39 | -11.55 | -52,373 | -57 |